Pilot study on the use of neuromuscular stimulation (FlowAid) in patients with therapy-resistant venous leg ulcer - FlowAid

St. Josef- und St. Elisabeth- Hospital gGmbH0 个研究点目标入组 20 人开始时间: 2018年5月17日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•o Men and women
•o Age > 18 years
•o BMI up to 40 kg/m2
•o Written consent
•o Patient in the vein centre
•o Primarily venous ulcer (recurrence or initial manifestation), diagnosis verified by DPPG and duplex sonography
•o Duration of the wound for at least 3 months
•o Stable wound progression with no healing tendency despite standard therapy in accordance with guidelines for at least 4 weeks (incl. phase-appropriate wound therapy and sufficient compression therapy)
•o Possibility and willingness to participate
•o Reduced mobility in the ankle/arthrogenic congestion syndrome

•o acute TVT/ OVT (< 6 months)
•o lack of intellectual capacity to agree and answer questions
•o lack of motor skills or home help for the home use of FlowAid according to the protocol
•o Contraindications for the use of Flowaid
•o significant other cause of venous leg ulcer
•o short-term necessity of in-patient therapy
•o Pregnancy and lactation
•o ABI < 0.5 or absolute systolic ankle artery pressure < 60mmHg

发起方